![](https://webarchive.library.unt.edu/eot2008/20081104182459im_/http://www.nci.nih.gov/images/spacer.gif) |
¿Preguntas sobre el cáncer?
![](https://webarchive.library.unt.edu/eot2008/20081104182459im_/http://www.nci.nih.gov/images/spacer.gif)
|
1-800-422-6237
(1-800-4-CANCER)
|
![](https://webarchive.library.unt.edu/eot2008/20081104182459im_/http://www.nci.nih.gov/images/spacer.gif)
|
Llame de lunes a viernes de 9:00 a.m. a 4:30 p.m., hora local en Estados Unidos y sus territorios. |
|
![](https://webarchive.library.unt.edu/eot2008/20081104182459im_/http://www.nci.nih.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081104182459im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081104182459im_/http://www.nci.nih.gov/images/spacer.gif)
| El cáncer primario de hígado en adultos en estadio III se divide en los estadio IIIA, IIIB y IIIC. En el estadio IIIA se puede presentar cualquiera de las siguientes situaciones: 1) uno o más tumores que miden más de cinco centímetros; o 2) un tumor que se ha diseminado hacia una rama principal de vasos sanguíneos cerca del hígado. |
![](https://webarchive.library.unt.edu/eot2008/20081104182459im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081104182459im_/http://www.nci.nih.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081104182459im_/http://www.nci.nih.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20081104182459im_/http://www.nci.nih.gov/images/spacer.gif) |